No Data
Trending Industry Today: MEDBOT-B Leads Losses In AI Medical Concept Stocks
The dreams of humanoid robots have been shattered? Related Concept stocks in Hong Kong all adjusted, with Horizon Robotics down nearly 10%.
① What core bottlenecks are currently faced by the humanoid robot industry? ② How does the inclusion of Horizon Robotics in the Hang Seng TECH Index and the upcoming release of restrictions create a "frozen and fiery" effect?
Goldman Sachs' research throws cold water on the situation: the turning point for humanoid robot technology remains unclear, and meaningful applications will take at least another five years!
Goldman Sachs believes that the humanoid robot H1 has only 19 degrees of freedom, making it still unable to handle complex and detailed tasks. At least in the next 2-3 years, it will be difficult for humanoid robots to achieve the same work efficiency as human workers. Meaningful applications are not expected for another 5-10 years.
The new drug development time is cut in half, diagnoses are more accurate, industry barriers are lowered... AI is transforming the Medical Industry in China.
On February 26, Deutsche Bank Analyst Cyrus Ng released a report stating that the entire Medical Industry in China, from drug development and diagnostics to Hospital management, will benefit from the AI revolution.
Hong Kong stock movement | MEDBOT-B (02252) rises over 5%. The surgical robot market has broad potential, with the company's core product overall Order volume exceeding 100 units last year.
MEDBOT-B (02252) increased by over 5%, as of publication, it rose by 5.59% to 24.55 HKD, with a trading volume of 0.401 billion HKD.
Trending Industry Today: XTALPI-P Leads Losses In AI Medical Concept Stocks
